s6y

Sunshine Biopharma Inc.

Ticker
SBFM, SBFMW
CIK
1402328
Industry
Pharmaceutical Preparations
Formerly
Sunshine Biopharma, Inc, Mountain West Business Solutions, Inc, mountain west business solutions,inc, mountain state business solutions,inc

Financials 94

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2024

All 94 financials filings

News 102

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 102 news filings

Ownership 66

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. SC 13G/A Major Shareholders
  5. 4 Statement of changes in beneficial ownership of securities
  6. SC 13G Major Shareholders
  7. SC 13G Major Shareholders
  8. SC 13G Major Shareholders
  9. 4 Statement of changes in beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 66 ownership filings

Prospectus 46

  1. S-1 General form of registration statement for all companies including face-amount certificate companies
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. DRSLTR Correspondence Related to Draft Registration Statement

All 46 prospectus filings

Proxies 41

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. DEF 14C Definitive information statements
  8. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  9. DEF 14C Definitive information statements
  10. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

All 41 proxies filings

Other 84

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G
  3. SCHEDULE 13G
  4. EFFECT Notice of Effectiveness
  5. SCHEDULE 13G/A
  6. EFFECT Notice of Effectiveness
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G/A
  9. SCHEDULE 13G
  10. SCHEDULE 13G

All 84 other filings